Mechanisms of angiogenesis in the brain

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 4, 1999, Pages 313-320

  Plate, Karl H ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Neurozentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BRAIN BLOOD FLOW; BRAIN CAPILLARY; CAPILLARY PROLIFERATION; GLIOBLASTOMA; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 0032920232     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199904000-00001     Document Type: Article

References (62)

1. Risau W. Differentiation of endothelium. FASEB J 1995;9:926-33
2. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-74
3. Bär T. The vascular system of the cerebral cortex. Adv Anat Embryol Cell Biol 1980;59:1-62
4. Robertson PL, Du Bois M, Bowman PD, Goldstein GW. Angiogenesis in the developing rat brain: An in vivo and in vitro study. Dev Brain Res 1985;23:219-23
5. Engerman RL, Pfaffenbach D, Davis MD. Cell turnover of capillaries. Lab Invest 1967;17:738-43
6. Korpelainen EI, Alitalo K. Signaling angiogenesis and lymphangiogenesis. Curr Opin Cell Biol 1998;10:159-64
7. Strömblad S, Cheresh DA. The role of cell adhesion molecules in angiogenesis. Trends Cell Biol 1996;6:462-68
8. Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis and growth factors: Ephrins enter the fray at the border. Cell 1998;93:661-64
9. Weller RO, Engelhardt B, Phillips MJ. Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways. Brain Pathol 1996;6:275-88
10. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25
11. Breier G, Clauss M, Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dynamics 1995;204:228-39
12. Millauer B, Wizigmann-Voos S, Schnürch H, et al. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993;72: 835-46
13. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992;114:521-32
14. Kremer C, Breier G, Risau W, Plate KH. Upregulation of flk-1/ VEGF receptor-2 by its ligand in a cerebral slice culture system. Cancer Res 1997;57:3852-59
15. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-28
16. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998;95:9349-54
17. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-79
18. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92:735-45
19. Lauren J, Gunji Y, Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol 1998;153:1333-39
20. Maisonpierre PC, Goldfarb M, Yancopoulos GD, Gao G. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 1993;8:1631-37
21. Schnürch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 1993;119:957-68
22. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG: Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997;81:567-74
23. Hanahan D: Signaling vascular morphogenesis and maintenance. Science 1997;277:48-50
24. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74
25. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171-80
26. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468-71
27. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60
28. Folkman J, D'Amore PA: Blood vessel formation: What is its molecular basis? Cell 1996;87:1153-55
29. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995;15:4738-47
30. Kleihues P, Burger PC, Plate KH, Ohgaki H, Cavenee WK. Glioblastoma. Pathology and genetics of tumours of the nervous system. Kleihues P, Cavenee WK, eds. Lyon: IARC, 1997:16-24
31. Weindel K, Moringlane JR, Marmé D, Weich HA. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid. Neurosurg 1994;35:439-49
32. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-45
33. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-48
34. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270: 19761-66
35. Damert A, Machein M, Breier G, et al. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997;57: 3860-64
36. Heiss JD, Papavassiliou E, Merill MJ, et al. Mechanism of dexamethasone suppression of brain tumour associated vascular permeability in rats. J Clin Invest 1996;98:1400-8
37. Machein MR, Kullmer J, Rönicke V, et al. Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropath Appl Neurobiol (in press)
38. Vaupel WP. Blood flow, oxygenation, tissue pH distribution, and bioenergetic status of tumors. Ernst Schering Research Foundation No. 23, Berlin, 1994
39. Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF-receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994;59:520-29
40. Hatva E, Kaipainen A, Jääskelainen J, Paetau A, Haltia M, Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995;146: 368-78
41. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marme D. Vascular endothelial growth factor upregulates its receptor fms-like tyrosine kinase (flt-1) and a soluble variant of flt-1 in human vascular endothelial cells. Cancer Res 1997;57:5421-25
42. Stratmann A, Risau W, Plate KH. Cell type specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998;153:1459-66
43. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998;3:513-20
44. Berkman RA, Merill MJ, Reinhold WC, et al. Expression of the vascular permeability/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993;91:153-59
45. Wizigmann-Voos S, Breier G, Risau W, Plate KH. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease associated and in sporadic hemangioblastoma. Cancer Res 1995;55:1358-63
46. Iliopoulos O, Levy AP, Jiang C, Kaelin Jr. WG, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996;93:10595-99
47. Böhling T, Hatva E, Plate KH, Haltia M, Alitalo K. Von Hippel-Lindau disease and Capillary Haemangioblastoma. In: Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the nervous system. IARC, 1997:179-81
48. Stratmann R, Krieg M, Haas R, Plate KH. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropath Exp Neurol 1997;56:1242-52
49. Krieg M, Marti HH, Plate KH. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood 1998;92:3388-93
50. Flamme I, Krieg M, Plate KH. Upregulation of vascular endothelial growth factor in stromal cells is correlated with upregulation of the transcription factor HRF/HIF-2α. Am J Pathol 1998;153:25-29
51. Ment LR, Stewart WB, Frone R, et al. Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Brain Res Dev Brain Res 1997;100:52-61
52. Patt S, Danner S, Theallier-Janko A, et al. Upregulation of vascular endothelial growth factor in severe chronic brain hypoxia of the rat. Neurosci Lett 1998;252:199-202
53. Kovácz Z, Ikezaki K, Samoto K, Inamura T, Fukui M. VEGF and flt: Expression time kinetics in rat brain infarct. Stroke 1996;27: 1865-73
54. Hayashi T, Abe K, Suzuki H, Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 1997;28:2039-44
55. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996;87:3336-43
56. Plate KH. Gene therapy of malignant glioma via inhibition of tumor angiogenesis. Cancer & Metastasis Reviews 1996;15:237-40
57. http://207.121.187.155/NCI_CANCER_TRIALS/zones/PressInfo/ Angio (update from 10/25/98)
58. Isner JM, Pieczek A, Schainfield R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996;348:370-74
59. Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors. Circulation 1998;97:645-50
60. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994; 25:1794-98
61. Rosenstein JM, Mani N, Silvermann WF, Krum JM. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998;95: 7086-91
62. Hayashi T, Abe K, Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 1998;18:887-95